For healthcare professionals only

Bmj Usa


BMJ 2005; 330 doi: (Published 17 March 2005) Cite this as: BMJ 2005;330:E341
  1. Patrick W Sullivan, assistant professor
  1. University of Colorado School of Pharmacy Pharmaceutical Outcomes Research Program Denver, CO

Following is an edited excerpt from one of the Rapid Responses generated by this article, all of which can be read in their entirety at—Editor

Cohen et al state that switching drugs to over the counter availability increases costs for most insured patients in the United States, but we have shown that the Rx-to-OTC switch …

View Full Text

Log in

Log in through your institution


* For online subscription